Citation Impact
Citing Papers
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Postmenopausal oestrogen treatment and stroke: a prospective study.
1988
Risk of exogenous estrogen therapy and endometrial cancer
1980
The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly Women
1993
Why Don't Physicians Follow Clinical Practice Guidelines?
1999 Standout
Human vascular smooth muscle cells express an estrogen receptor isoform
1995
A Multifactorial Intervention to Reduce the Risk of Falling among Elderly People Living in the Community
1994 Standout
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
2000 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Falls Among Older Persons: A Public Health Perspective
1992
Preventing Falls in Elderly Persons
2003 Standout
Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome
1995
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
1995
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1987
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study
1989
Hormone Replacement Therapy and the Risk for First Hip Fracture
1990
Exercise and Other Factors in the Prevention of Hip Fracture
1991
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins
1991
Estrogen replacement therapy and protection from acute myocardial infarction
1988
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Epidemiology of Coronary Heart Disease—Influence of Alcohol
1994
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Gynecologic consequences of long-term, unopposed estrogen replacement therapy
1988
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
1992
Risk Factors for Falls among Elderly Persons Living in the Community
1988 Standout
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
1997
Risk factors and noncontraceptive estrogen use in women with and without coronary disease
1989
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
The joint effect of risk factors on endometrial cancer
1988
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Anthropometric Indicators and Hip Fracture
1989
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysis
1990
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Actual Causes of Death in the United States, 2000
2004 Standout
Prospective study of exogenous hormone use and breast cancer in seventh-day adventists
1989
Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women
1988
Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women
1991
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
1995
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
1991 Standout
Production and Actions of Estrogens
2002 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
2008
Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
1990 Standout
Estrogen replacement therapy and the risk of venous thrombosis
1992
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Prevalence and determinants of estrogen replacement therapy in elderly women
1990
Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies
1990
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Fractures and lifestyle: effect of cigarette smoking, alcohol intake, and relative weight on the risk of hip and forearm fractures in middle-aged women.
1988
Replacement Estrogens and Endometrial Cancer
1979
Predominance of Early Endometrial Cancers After Long-term Estrogen Use
1980
Endometrial Cancer and Estrogen Use
1979
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women
1977
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Involutional Osteoporosis
1986 Standout
The effects of oestrogens and progestogens on the postmenopausal endometrium
1978
Estrogen use and cardiovascular disease
1986
Biologic Effects of Transdermal Estradiol
1986
Osteopenia in hypoestrogenic young women with anorexia nervosa
1984
Menopausal Estrogen Replacement Therapy and Breast Cancer
1991
Recent and Past Use of Conjugated Estrogens in Relation to Adenocarcinoma of the Endometrium
1980
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
PREVENTION AND TREATMENT OF ENDOMETRIAL DISEASE IN CLIMACTERIC WOMEN RECEIVING ŒSTROGEN THERAPY
1979
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
1996
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Physician Policies on the Use of Preventive Hormone Therapy
1997
Endometrial Cancer in Relation to Patterns of Menopausal Estrogen Use
1979
Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects
1985
Psychotropic Drug Use and the Risk of Hip Fracture
1987
Methodologic standards and contradictory results in case-control research
1979
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Predictors of hip fractures in elderly men
1995
The Effects of Estrogens and Progestogens on the Endometrium
1987
Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program
1986
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function
1998
Alternative Analytic Methods for Case-Control Studies of Estrogens and Endometrial Cancer
1978
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered
1986
The Epidemiology of Osteoporosis
1996
Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation
1981
Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy
1987
Exogenous estrogen and endometrial carcinoma: Case-control and incidence study
1977
Postmenopausal Estrogen Use and Coronary Atherosclerosis
1988
Menopausal estrogen use and the risk of breast cancer
1986
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
1998
The epidemiology of osteoporosis. The oriental perspective in a world context.
1996
The epidemiology of endometrial cancer in young women
1983
Effects of long-term estrogen replacement therapy
1979
Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal Osteoporosis
1982
Race and sex differences in hip fracture incidence.
1984
Survival among women with endometrial cancer: A comparison of estrogen users and nonusers
1982
Blood pressure, stroke, and coronary heart disease
1990 Standout
A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
1985
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
1991
Drug-induced cancer
1981
A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in Nurses
1985 Standout
Estrogen use and breast cancer interaction with body mass
1983
Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium
1981
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
ŒSTROGEN USE AND SURVIVAL IN ENDOMETRIAL CANCER
1980
Menopause and Coronary Heart Disease
1978
Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures
1985
Reduction of cardiovascular disease—related mortality among postmenopausal women who use hormones: Evidence from a national cohort
1991
Serum androgens and estrogens in postmenopausal women with and without endometrial cancer
1980
Risk Factors for Falls as a Cause of Hip Fracture in Women
1991
Estrogen use — Risk of endometrial carcinoma
1978
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Estrogen Use and All-Cause Mortality
1983
Role of Hormones in the Etiology and Prevention of Endometrial and Breast Cancer
1982
Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease
2002
Estrogen Replacement Therapy: Indications and Complications
1983
A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses
1981
The prevention of endometrial cancer in postmenopausal women with progestogens
1978
Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50
1985
Human vascular smooth muscle cells contain functional estrogen receptor.
1994
Mortality in women following hip fracture
1983
Oestrogen Therapy and the Menopausal Syndrome
1977
High Density Lipoprotein Subfractions during Oral and Cutaneous Administration of 17β-Estradiol to Menopausal Women*
1983
Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981.
1984
The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns
1980
Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens
1985
Effects of long-term estrogen replacement therapy
1979
Estrogen use and myocardial infarction risk: A case-control study
1984
Estrogen and endometrial cancer: Cases and two control groups from North Carolina
1980
The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.
1981
Actual Causes of Death in the United States
1993 Standout
Endogenous hormones as a major factor in human cancer.
1982
Human Aging: Usual and Successful
1987 StandoutScience
Contribution of the Environment to Cancer Incidence: An Epidemiologic Exercise
1977
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1988
Oestrogens and endometrial cancer: Effect of other risk factors on the association
1980
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Postmenopausal Estrogen Use and Heart Disease Risk Factors in the 1980s
1989
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women
1987
Works of Mary E. Arthur being referenced
Inferior Vena Cava Diameter (IVCD) Measured with Transesophageal Echocardiography (TEE) Can Be Used to Derive the Central Venous Pressure (CVP) in Anesthetized Mechanically Ventilated Patients
2008
Reserpine and Breast Cancer in a Retirement Community
1975
MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASE
1981
Estrogens and Endometrial Cancer in a Retirement Community
1976
Menopausal Estrogen Therapy and Hip Fractures
1981